John Gillard - 18 Mar 2026 Form 3/A - Amendment Insider Report for TRINITY BIOTECH PLC (TRIB)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
3/A - Amendment
Accepted by SEC
08 Apr 2026, 06:48:38 UTC
Original report date
03 Apr 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ John Gillard

Key filing fact

John Gillard filed Form 3/A - Amendment for TRINITY BIOTECH PLC (TRIB) on 08 Apr 2026.

Key facts

  • This page summarizes John Gillard's Form 3/A - Amendment filing for TRINITY BIOTECH PLC (TRIB).
  • 0 reported transactions and 6 derivative rows are listed below.
  • Accepted by SEC: 08 Apr 2026, 06:48.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3/A - Amendment disclosures.

View source filing

Reporting Owners (1)

CIK 0002126172 Primary reporting owner

Gillard John

Relationship
Director
Address
TRINITY BIOTECH PLC, IDA BUSINESS PARK, WICKLOW, BRAY, IRELAND
Signature
/s/ John Gillard
Signature date
08 Apr 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TRIB holding

ADS

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
10,000
Date
18 Mar 2026
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TRIB holding Derivative

ADS OPTIONS

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
ADS OPTIONS
Underlying amount
7,500
Exercise price
$13.45
TRIB holding Derivative

ADS OPTIONS

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
ADS OPTIONS
Underlying amount
40,000
Exercise price
$5.70
TRIB holding Derivative

ADS OPTIONS

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
ADS OPTIONS
Underlying amount
43,750
Exercise price
$2.40
TRIB holding Derivative

ADS OPTIONS

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
ADS OPTIONS
Underlying amount
29,167
Exercise price
$2.40
TRIB holding Derivative

ADS OPTIONS

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
ADS OPTIONS
Underlying amount
35,000
Exercise price
$5.45
TRIB holding Derivative

ADS OPTIONS

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
ADS OPTIONS
Underlying amount
29,167
Exercise price
$2.40
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

See Exhibit 99.1 for additional holdings details.

SEC remarks

This Amendment to Form 3 is being filed to include one additional holding that was inadvertently omitted from the original filing due to the 30-line limit of the electronic form. This additional holding is set forth in Exhibit 99.1, which is attached hereto and incorporated herein by reference.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .